Wikipedia:Articles for deletion/Aristopharma

The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.

The result was delete. ✗plicit 12:58, 28 February 2022 (UTC)[reply]

Aristopharma[edit]

[Hide this box] New to Articles for deletion (AfD)? Read these primers!

(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

The references do not show the subject meets the notability criteria for companies. Vinegarymass911 (talk) 07:32, 16 February 2022 (UTC)[reply]

Note: This discussion has been included in the list of Companies-related deletion discussions. Vinegarymass911 (talk) 07:32, 16 February 2022 (UTC)[reply]
Note: This discussion has been included in the list of Bangladesh-related deletion discussions. Vinegarymass911 (talk) 07:32, 16 February 2022 (UTC)[reply]

Relisted to generate a more thorough discussion and clearer consensus.
Please add new comments below this notice. Thanks, Liz ^{Read! Talk!} 05:20, 23 February 2022 (UTC)[reply]

Note: This discussion has been included in the deletion sorting lists for the following topics: Organizations and Medicine. CAPTAIN RAJU^(T) 08:20, 23 February 2022 (UTC)[reply]
Delete No secondary sources for notability. First and third references are press releases, second is from company's own web site.— rsjaffe 🗣️ 11:29, 23 February 2022 (UTC)[reply]
Delete This is an organization/company therefore WP:NCORP applies. None of the references meets the criteria for establishing notability, topic fails NCORP. HighKing⁺⁺ 16:31, 26 February 2022 (UTC)[reply]

The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.